Skip to main content

Table 2 Number of patients with demonstrable clinical utility (four domains)

From: The clinical utility of rapid exome sequencing in a consanguineous population

Changes in acute patient management or clinical outcome

n = 75a

 Changes in medications

11

 Changes in invasive procedures

16

 Changes in clinical outcome

23

 Decision about palliative care

13

 Decision about transplant

30

 Changes in diet

3

 Changes in imaging studies

1

Changes in communication

n = 69a

 Communicate a specific diagnostic label not suspected prior to flash ES

66

 Explains the natural history of disease

67

Changes in subsequent test ordering

n = 6

Changes in other care

n = 78a

 Counseling

74

 Further monitoring

10

  1. aPlease note there is an overlap in the cases and corresponding categories